Sunday, September 03, 2017 9:18:12 AM
2 goals are key for us
1. day 74 letter - 90% of all NDA applications will undergo initial review and get a formal communication in terms of any issues with the applications and if company needs to submit additional information. If there are no issues - same will be communicated in Day 74 letter - by mail, e-mail, teleconf etc
74 days KT-302 complete on 13th Oct - so we can expect an update of NDA for next step of review by 20th Oct
2. Final review goals - 90% of NDA will undergo final review and acted upon - within 10 months - the 10 months start after 60 calendar days of the initial application date - this means 12 months of initial application date
For KT-302 - this means 31st Jul 2018
FDA also will give companies update on one late cycle review of application.
So for us as investors - wait for day 74 letter update in late Oct and possible interim update in Q1-2018 and final decision by July 2018
This will be long wait period with nearly no other action unless co finds a new partner of BO after 74 day response with no issues.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM